The EMCDDA is offering a new series of webinars around the theme of COVID-19. The purpose of the webinars is to help those working in the drugs field understand how drug users, and those supporting them, are coping with the pandemic and to share knowledge and experience. The webinars will give a voice to key professionals working in the drugs field and will allow for a panel discussion on emerging challenges. The sessions, chaired by EMCDDA staff members, are open to EMCDDA employees, the Reitox network and professionals working in the domain.
In the trial phase, the webinars will vary in length and frequency and will be adjusted following participants’ evaluations. The agency is testing the webinar format as a new EMCDDA product type.
Background: this is the 6th EMCDDA webinar on the Coronavirus. It will be exploring with the help of three experts from Northern, Central, Southern European EU countries (Finland, Greece and The Netherlands) whether the COVID-19 related emergency is having or is going to have any impact on Drugs Policy.
Speakers: Speakers are Horizontal Drugs Group members with policy responsibility is their respective national administration.
Format: EMCDDA Director opening remarks, panelists questions guided discussion, Q&A from attendees.
Questions will be:
Date and time: 7 July 12.00-13.30 (WET/Lisbon) 13.00-14.30 (CET/Brussels)